Opendata, web and dolomites

EyeWideVision SIGNED

An assessment and treatment tool for visual dysfunctions in children

Total Cost €


EC-Contrib. €






 EyeWideVision project word cloud

Explore the words cloud of the EyeWideVision project. It provides you a very rough idea of what is the project "EyeWideVision" about.

dysfunctions    period    clinical    months    children    treatment    standard    95    visual    15    usd    wivi    million    detection   

Project "EyeWideVision" data sheet

The following table provides information about the project.


Organization address
address: C/CANONIGO ALMERA, 10 2 2
postcode: 08032
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme /SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

It is estimated that approximately 30-50% of the general population in children (5-15 years old) suffer from some visual functional dysfunctions, and 10% of them have a serious impairment that affects their daily life. Nevertheless, once detected such dysfunctions can be improved in 95-100% of the cases through training or therapy, but only 2% of these patients are being treated. To solve this problem, we have developed WIVI. WIVI is an assessment and treatment tool for visual dysfunctions detection based on immersive 3D techniques, which examines in a multiparametric way the visual system in its full extension, i.e., it provides a complete cognitive, neural and physic phases assessment. WIVI reduces the standard treatment period from 6 months to 2,5 months, and each session duration is reduced by 75%. Price wise, WIVI allows to save between 58% up to 85% of the total cost of current alternatives. Our product has been tested on 15 children between 5 and 17 years old and on 40 adults in the age range 18 to 70, reaching 95% of accuracy in measurements. The global clinical devices for the visual function assessment market is anticipated to grow from an estimated USD 29,171 million in 2014 to USD 42,685 million in 2020 at a CAGR of 6.5% during the forecast period. The overall objective of the WIVI business project is to establish WIVI as a worldwide standard in visual dysfunction assessment and treatment, supporting it in real-time high detection rates, cheaper and faster clinical practices.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EYEWIDEVISION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EYEWIDEVISION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

ICU-CARE (2018)

Delivering BEACON Caresystem – a ground-breaking ICT-enabled ICU bed-side assistant providing recommenda-tions for critical mechanical ventilation support for better care and reduced costs.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More